Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Bandari
Mohan Bandari, Hyderabad IN
| Patent application number | Description | Published |
|---|---|---|
| 20090259051 | CARVEDILOL PHOSPHATE SESQUIHYDRATE - The present invention relates a novel crystalline 1-(Carbazol-4-yloxy-3-[[2-(o-methoxyphenoxy) ethyl]amino]-2-propanol phosphate sesquihydrate (Carvedilol dihydrogenphosphate sesquihydrate), methods of preparing the sesquihydrate by adding phosphoric acid to a suspension of Carvedilol in water, water miscible solvents or a mixture of water and water miscible organic solvent followed by isolating the product directly or by adding solvent. | 10-15-2009 |
| 20110034701 | ONE POT PROCESS FOR THE PREPARATION OF CANDESARTAN - Present invention is to provide one pot synthesis of candesartan without isolating the ester intermediate. | 02-10-2011 |
| 20110092708 | PROCESS FOR THE PREPARATION OF MONTELUKAST AND ITS SALTS THEREOF - The present invention relates to the alkyl amine salts of Montelukast and methods for their preparation and conversion of Montelukast amine salts to Montelukast or Montelukast alkali/alkaline salt. | 04-21-2011 |
Mohan Bandari, Secunderabad IN
| Patent application number | Description | Published |
|---|---|---|
| 20090018344 | PROCESS FOR THE PREPARATION OF CANDESARTAN CILEXETIL - The invention relates to process for the preparation of Candesartan cilexetil. More particularly, it relates to the preparation of pure candesartan cilexetil by the deprotection of Trityl candesartan cilexetil with inorganic acids. | 01-15-2009 |
| 20090062550 | Process for the Large Scale Production of Rizatriptan Benzoate - The present invention provides a method for preparing pure Rizatriptan benzoate having purity more than 99.5% and dimer impurity less than 0.1% comprises, i) Condensation of 1,2,4-Triazole with 4-Nitro benzyl bromide to yield 1-(4-nitrophenyl)methyl-1,2,4-triazole ii) Reducing the 1-(4-nitrophenyl)methyl-1,2,4-triazole to give 1-(4-aminophenyl)methyl-1,2,4-triazole iii) Converting 1-(4-aminophenyl)methyl-1,2,4-triazole to 1-(4-hydrazinophenyl)methyl-1,2,4-triazole hydrochloride iv) Condensing the hydrazine derivative with 4-(Dimethylamino) butanal diethylacetal to get Rizatriptan and v) Salification of Rizatriptan to Rizatriptan benzoate. | 03-05-2009 |
| 20090240064 | CRYSTALLINE FORM OF ATORVASTATIN HEMI-CALCIUM - The present invention relates to a new crystalline form of Atorvastatin hemi-calcium and also relates to a process for preparation of the same by treating Atorvastatin hemi-calcium amorphous form or form-I or mixture of amorphous and crystalline forms with methanol. | 09-24-2009 |
Sreedhar Bandari, Karimnagar IN
| Patent application number | Description | Published |
|---|---|---|
| 20100048607 | FORMULATIONS COMPRISING PALONOSETRON - Pharmaceutical compositions comprising palonosetron and its pharmaceutically acceptable salts, in the form of a ready-to-use solution or a lyophilized form. Specific embodiments of the invention relate to stable pharmaceutical formulations of palonosetron and its pharmaceutically acceptable salts, wherein the formulation does not comprise a chelating agent or an antioxidant. | 02-25-2010 |